基于CiteSpace对交感神经与高血压关系研究的可视化分析

Abstract
Figure/Table
References (26)
Related Citation (15)

Download: PDF (1705 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To discuss the research status, hotspot and future development of the relationship between sympathetic nerve and hypertension in recent ten years. Methods The Web of Science core collection database was used as literature source, relevant literatures from 2010 to 2019 were collected and imported into CiteSpace software for co-occurrence analysis of authors, countries, institutions, and keywords as well as co-citation analysis of literatures and journals. Results A total of 2115 literatures were included, among which MARKUS P SCHLAICH was the author with the highest number of published literatures. The most important country in the cooperative network was the United States; the principal research institution was Monash University; key words: resistant hypertension, renal denervation, angiotensin Ⅱ, etc. Key words culsters: there were six clusters in total, they were renin receptor, renal dnervation, resting heart rate, sleep apnea, oxidative stress, and chronic intermittent hypoxia. Conclusion The application of CiteSpace software in the bibliometric analysis on the literature related to the relationship between sympathetic nerve and hypertension show the current research status and hot spots, predict the possible research direction in the future, and provide reference for clinical treatment.

Key words： Hypertension Sympathetic nerve Mechanism Web of Science CiteSpace Visual analysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHOU Yu1
	2 HU Yuanhui2 CHAI Ruoning2 ZHANG Xuesong2 DU Yihang2 CHU Yuguang2

Cite this article:

ZHOU Yu1,2 HU Yuanhui2 CHAI Ruoning2 ZHANG Xuesong2 DU Yihang2 CHU Yuguang2. Visual analysis of the relationship between sympathetic nerve and hypertension based on CiteSpace[J]. 中国医药导报, 2021, 18(26): 17-23.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I26/17

[1] Mills KT，Stefanescu A，He J. The global epidemiology of hypertension [J]. Nat Rev Nephrol，2020，16（4）：223-237.
[2] Dhungana RR，Pandey AR，Shrestha N. Trends in the Prevalence，Awareness，Treatment，and Control of Hypertension in Nepal between 2000 and 2025：A Systematic Review and Meta-Analysis [J]. Int J Hypertens，2021，2021：6610649.
[3] Abariga SA，Al Kibria GM，Albrecht JS. Impact of the 2017 American College of Cardiology/American Heart Association Guidelines on Prevalence of Hypertension in Ghana [J]. Am J Trop Med Hyg，2020，102（6）：1425-1431.
[4] Iyonaga T，Shinohara K，Mastuura T，et al. Brain perivascular macrophages contribute to the development of hypertension in stroke-prone spontaneously hypertensive rats via sympathetic activation [J]. Hypertens Res，2020，43（2）：99-110.
[5] DeLalio LJ，Sved AF，Stocker SD. Sympathetic Nervous System Contributions to Hypertension：Updates and Therapeutic Relevance [J]. Can J Cardiol，2020，36（5）：712-720.
[6] Yoo JK，Fu Q. Impact of sex and age on metabolism，sympathetic activity，and hypertension[J]. FASEB J，2020，34（9）：11337-11346.
[7] Sun W，Huang P，Song H，et al. Bibliometric analysis of acute pancreatitis in Web of Science database based on CiteSpace software [J]. Medicine，2020，99（49）：e23208-e23208.
[8] Ye LP，Zhang XP. Visualizing the knowledge structure of medication-adherence research：A bibliometric analysis （1997-2016） [J]. Int J Health Plann Manage，2019，34（4）：1333-1353.
[9] Grassi G，Pisano A，Bolignano D，et al. Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates：Systematic Reviews and Meta-Analyses [J]. Hypertension，2018，72（2）：483-491.
[10] Grassi G，Ram VS. Evidence for a critical role of the sympathetic nervous system in hypertension [J]. J Am Soc Hypertens，2016，10（5）：457-466.
[11] Esler MD，Krum H，Sobotka PA，et al. Renal sympathetic denervation in patients with treatment-resistant hypertension （The Symplicity HTN-2 Trial）：a randomised controlled trial [J]. Lancet，2010，376（9756）：1903-1909.
[12] Fischer T. Renal sympathetic denervation for treatment of drug-resistant hypertension：one-year results from the Symplicity HTN-2 randomized，controlled trial [J]. Orv Hetil，2014，155（21）：843.
[13] Krum H，Schlaich M，Whitbourn R，et al. Catheter-based renal sympathetic denervation for resistant hypertension：a multicentre safety and proof-of-principle cohort study [J]. Lancet 2009，373（9671）：1275-1281.
[14] Schlaich MP，Sobotka PA，Krum H，et al. Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension [J]. N Engl J Med，2009，361（9）：932-934.
[15] Mahfoud F，Schlaich M，Kindermann I，et al. Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension A Pilot Study [J]. Circulation，2011，123（18）：1940-1946.
[16] Krum H，Schlaich MP，Bohm M. Percutaneous renal denervation in patients with treatment-resistant hypertension：final 3-year report of the Symplicity HTN-1 study [J]. Lancet，2014，383（9917）：602.
[17] Brandt MC，Mahfoud F，Reda S，et al. Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension [J]. J Am Coll Cardiol，2012，59（10）：901-909.
[18] Hering D，Lambert EA，Marusic P，et al. Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension [J]. Hypertension，2013，61（2）：457-464.
[19] Hering D，Mahfoud F，Walton AS，et al. Renal Denervation in Moderate to Severe CKD [J]. J Am Soc Nephrol，2012，23（7）：1250-1257.
[20] Mahfoud F，Cremers B，Janker J，et al. Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant Hypertension [J]. Hypertension，2012，60（2）：419-424.
[21] Schlaich MP，Sobotka PA，Krum H，et al. Renal Denervation as a Therapeutic Approach for Hypertension Novel Implications for an Old Concept [J]. Hypertension，2009， 54（6）：1195-1201.
[22] Kandzari DE，Bhatt DL，Sobotka PA，et al. Catheter-Based Renal Denervation for Resistant Hypertension：Rationale and Design of the SYMPLICITY HTN-3 Trial [J]. Clin Cardiol，2012，35（9）：528-535.
[23] Simms AE，Paton JFR，Pickering AE，et al. Amplified respiratory-sympathetic coupling in the spontaneously hypertensive rat：does it contribute to hypertension [J]. J Physiol，2009，587（3）：597-610.
[24] Manta E，Kouremeti M，Kakouri N，et al. Correlations of attended and unattended blood pressure with sympathetic nervous system activity in essential hypertension [J]. Eur Heart J，2020，41：2754.
[25] Flack JM，Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines [J]. Trends Cardiovas Med，2020，30（3）：160-164.
[26] Hiremath S，Sapir-Pichhadze R，Nakhla M，et al. Hypertension Canada’s 2020 Evidence Review and Guidelines for the Management of Resistant Hypertension [J]. Can J Cardiol，2020，36（5）：625-634.